AstraZeneca PLC (AZN)
89.36
-0.58
(-0.64%)
USD |
NASDAQ |
Jan 21, 11:07
AstraZeneca Market Cap: 277.06B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 96.38B |
| Amgen, Inc. | 182.25B |
| Gilead Sciences, Inc. | 156.71B |
| Regeneron Pharmaceuticals, Inc. | 78.12B |
| Sanofi | 111.90B |
Market Cap Related Metrics
| PE Ratio | 29.67 |
| PS Ratio | 4.804 |
| PEG Ratio | 0.6637 |
| Price to Book Value | 6.038 |
| Price to Free Cash Flow | 28.26 |
| Price | 89.36 |
| Earnings Yield | 3.37% |
| PEGY Ratio | 0.6389 |
| Operating PE Ratio | 21.95 |
| Normalized PE Ratio | 29.07 |